群馬大学医学部附属病院は、群馬県前橋市にある国立大学法人群馬大学の附属病院

During the past decade, Gunma University Hospital conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 23 clinical trials were completed, i.e. on average, 51.1% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 14 clinical trials were completed. i.e. 60.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gunma University Hospital" #1 sponsor was "Pfizer" with 9 trials, followed by "Janssen Research & Development, LLC" with 7 trials sponsored, "Bayer" with 6 trials sponsored, "Celgene" with 4 trials sponsored and "Hoffmann-La Roche" with 4 trials sponsored. Other sponsors include 27 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gunma University Hospital" #1 collaborator was "Boehringer Ingelheim" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator, "Foundation Medicine" with 1 trials as a collaborator and "Genmab" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Gunma University Hospital" are "Multiple Myeloma" (5 trials), "Alzheimer Disease" (3 trials), "Colitis, Ulcerative" (3 trials), "Crohn Disease" (3 trials) and "Epithelial Ovarian Cancer" (3 trials). Many other conditions were trialed in "Gunma University Hospital" in a lesser frequency.

Most popular intervention types in "Gunma University Hospital" are "Drug" (55 trials), "Other" (5 trials), "Biological" (4 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Bortezomib" (3 trials), "Carfilzomib" (3 trials), "Dexamethasone" (3 trials) and "Bendamustine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Gunma University Hospital" are 55 trials for "All" genders, 4 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Gunma University Hospital". undefined are not yet recruiting, 20 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Gunma University Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Gunma University Hospital, 2 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 46 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".